TANGORX
DEAD

Serial Number

90522672

Owner

Tango340b LLC

Attorney

Giovanna H. Fessenden

Filing Date

Feb 10, 2021

Add to watchlist:

No watchlists yet
View on USPTO

TANGORX Trademark

Serial Number: 90522672

TANGORX is a trademark filed by Tango340b LLC on February 10, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Tango340b LLC (7 trademarks)

Albany, NY 122072543

Entity Type: 16

Trademark Details

Filing Date

February 10, 2021

Registration Date

Not Registered

Published for Opposition

March 8, 2022

Goods & Services

Downloadable software for administering pharmacy reimbursement programs; downloadable software for drug and pharmaceutical inventory management, tracking, managing, and reporting of information in connection with Federal 340B pharmacy programs and discount prescription drug programs for eligible organizations and pharmacies to allow them to offer drug distribution services on behalf of covered entities in compliance with the Federal 340B pharmacy programs, and discount prescription drug programs; downloadable software for placing prescription medicine orders and for interacting with pharmacies, hospitals, physicians, medical staff, and health professionals

Health care and pharmacy benefits claims recovery services in the nature of insurance subrogation, namely, coordination of insurance benefits programs claims processing and administration; insurance administration services, namely, insurance subrogation and assisting others with collecting insurance premiums in the nature of the collection of money owed by patients and insurance providers; pharmacy benefit management services; pharmacy benefit and claims processing management services

Business management and administration of Federal 340B pharmaceutical programs and discount prescription drug programs; business and inventory management services provided to eligible organizations in the healthcare fields for controlling drug inventories; business assistance, advisory services, and consultancy, namely, regulatory compliance reporting in the nature of submission management, namely, assisting others in preparing and filing applications for eligible health care facilities in the fields of Federal 340B pharmaceutical programs and discount prescription drug programs with governmental regulatory bodies; business consulting services, relating to operations management services, managing the flow of inventory, business information, and accounts receivable billing between health centers, pharmacies, wholesalers, and insurance companies; audit support services, namely, audit policy and procedures guidance, review of audit documents, data and procedures, preparation, organization, and presentation of the documents and data requested by a government body or third party, and providing business advice on government or third party audit processes, policies, and strategies; specialty retail pharmacy services; interactive record-keeping services for use in regulatory compliance by professionals in the medical and pharmaceutical fields; providing an online computer database for collecting and reporting pharmacy management and drug dispensing information for business purposes; data management services, namely, electronic data collection, on-line claims management, and financial reconciliation of accounts on behalf of others; administration coordination services in the nature of facilitating administrative coordination between health care facilities, pharmacies, and insurance plans; inventory management; Business consulting services in the fields of the business management and administration of Federal 340B pharmacy programs and discount prescription drug programs; retail pharmacy services

Regulatory compliance consulting in the fields of healthcare, Federal 340B pharmacy programs, and discount prescription drug programs; regulatory compliance consulting services in the fields of healthcare and Federal 340B pharmaceutical program in the nature of compliance, auditing, and reviewing contracts, systems, procedures, and policies, all for compliance with government regulations; regulatory compliance consulting in the field of assisting others in preparing and filing applications for eligible health care facilities and pharmacies in the fields of Federal 340B pharmaceutical programs and discount prescription drug programs with governmental regulatory bodies

Consulting services in the field of healthcare; medical and pharmaceutical consultation; preparation of prescriptions in pharmacies

Providing temporary use of non-downloadable software for administering pharmacy reimbursement programs; Software as a service (SaaS) services featuring software for drug and pharmaceutical inventory management, tracking, managing, and reporting of information in connection with Federal 340B pharmacy programs and discount prescription drug programs for eligible organizations and pharmacies to allow them to offer drug distribution services on behalf of covered entities in compliance with the Federal 340B pharmacy programs, and discount prescription drug programs; Providing temporary use of non-downloadable computer software that enables users to purchase prescription medicines via a global computer network; Providing a website featuring technology that enables users to purchase prescription medicine via a global computer network

Filing History

ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Sep 21, 2022 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
Sep 21, 2022 ABN4
OPPOSITION TERMINATED NO. 999999
Sep 21, 2022 OP.T
OPPOSITION SUSTAINED NO. 999999
Sep 21, 2022 OP.S
OPPOSITION INSTITUTED NO. 999999
Apr 6, 2022 OP.I
OPPOSITION PAPERS RECEIVED AT TTAB
Apr 6, 2022 OPPF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 8, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 16, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 2, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 2, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 2, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 2, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 2, 2022 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 1, 2022 ZZZX
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 8, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 8, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 8, 2021 REAP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 21, 2021 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 7, 2021 CNSA
ASSIGNED TO EXAMINER
Sep 6, 2021 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 28, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 28, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 28, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 28, 2021 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 14, 2021 NWOS
NEW APPLICATION ENTERED
Feb 15, 2021 NWAP